coca-cola europacific partners plc - CCEP
CCEP
Close Chg Chg %
105.76 0.79 0.75%
Pre-Market
106.55
+0.79 (0.75%)
Volume: 1.60M
Last Updated:
Sep 8, 2026, 4:00 PM EDT
Company Overview: coca-cola europacific partners plc - CCEP
CCEP Key Data
| Open $105.50 | Day Range 105.50 - 107.63 |
| 52 Week Range 84.66 - 113.64 | Market Cap $46.87B |
| Shares Outstanding 443.22M | Public Float 197.52M |
| Beta 0.49 | Rev. Per Employee N/A |
| P/E Ratio 20.43 | EPS $2.21 |
| Yield 225.98% | Dividend $0.96 |
| EX-DIVIDEND DATE May 15, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.55M |
CCEP Performance
| 1 Week | 0.75% | ||
| 1 Month | -1.61% | ||
| 3 Months | 7.26% | ||
| 1 Year | 18.77% | ||
| 5 Years | 82.73% |
CCEP Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
22
Full Ratings ➔
About coca-cola europacific partners plc - CCEP
Coca-Cola Europacific Partners plc engages in the distribution and sale of non-alcoholic ready-to-drink beverages. It operates through the following geographical segments: Iberia, Germany, Great Britain, France, Belgium and Luxembourg, Netherlands, Norway, Sweden, and Iceland. The Iberia segment refers to Spain, Portugal, and Andorra. The France segment includes continental France and Monaco. The company was founded on August 4, 2015 and is headquartered in Uxbridge, the United Kingdom.
CCEP At a Glance
Coca-Cola Europacific Partners plc
Pemberton House
Uxbridge, Greater London UB8 1EZ
| Phone | 44-1895-231313 | Revenue | 23.59B | |
| Industry | Beverages: Non-Alcoholic | Net Income | 2.19B | |
| Sector | Consumer Non-Durables | 2025 Sales Growth | 6.698% | |
| Fiscal Year-end | 12 / 2026 | Employees | 39,000 | |
| View SEC Filings |
CCEP Valuation
| P/E Current | 20.432 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 18.871 |
| Price to Sales Ratio | 1.753 |
| Price to Book Ratio | 4.427 |
| Price to Cash Flow Ratio | 13.19 |
| Enterprise Value to EBITDA | 12.699 |
| Enterprise Value to Sales | 2.261 |
| Total Debt to Enterprise Value | 0.235 |
CCEP Efficiency
| Revenue/Employee | 604,830.968 |
| Income Per Employee | 56,197.394 |
| Receivables Turnover | 6.081 |
| Total Asset Turnover | 0.701 |
CCEP Liquidity
| Current Ratio | 0.801 |
| Quick Ratio | 0.597 |
| Cash Ratio | 0.126 |
CCEP Profitability
| Gross Margin | 34.869 |
| Operating Margin | 13.392 |
| Pretax Margin | 12.291 |
| Net Margin | 9.291 |
| Return on Assets | 6.514 |
| Return on Equity | 24.363 |
| Return on Total Capital | 10.072 |
| Return on Invested Capital | 10.879 |
CCEP Capital Structure
| Total Debt to Total Equity | 136.49 |
| Total Debt to Total Capital | 57.715 |
| Total Debt to Total Assets | 35.799 |
| Long-Term Debt to Equity | 130.491 |
| Long-Term Debt to Total Capital | 55.178 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Coca-cola Europacific Partners Plc - CCEP
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 18.20B | 19.79B | 22.11B | 23.59B | |
Sales Growth
| +11.90% | +8.70% | +11.73% | +6.70% | |
Cost of Goods Sold (COGS) incl D&A
| 11.67B | 12.68B | 14.50B | 15.36B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 857.60M | 856.24M | 1.01B | 1.04B | |
Depreciation
| 751.45M | 705.97M | 812.35M | 870.13M | |
Amortization of Intangibles
| 106.15M | 150.28M | 196.87M | 171.54M | |
COGS Growth
| +13.57% | +8.64% | +14.38% | +5.92% | |
Gross Income
| 6.53B | 7.11B | 7.60B | 8.23B | |
Gross Income Growth
| +9.02% | +8.81% | +6.99% | +8.18% | |
Gross Profit Margin
| +35.88% | +35.91% | +34.39% | +34.87% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 4.15B | 4.58B | 5.00B | 5.07B | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 4.15B | 4.58B | 5.00B | 5.07B | |
SGA Growth
| +7.39% | +10.21% | +9.27% | +1.27% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 134.52M | 28.11M | 324.51M | 163.64M | |
EBIT after Unusual Expense
| 2.24B | 2.50B | 2.28B | 3.00B | |
Non Operating Income/Expense
| (83.03M) | 38.92M | 69.23M | 218.94M | |
Non-Operating Interest Income
| 70.42M | 70.27M | 91.94M | 116.24M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 101.94M | 156.76M | 250.95M | 314.87M | |
Interest Expense Growth
| -6.25% | +53.77% | +60.09% | +25.47% | |
Gross Interest Expense
| 101.94M | 156.76M | 250.95M | 314.87M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 2.06B | 2.38B | 2.09B | 2.90B | |
Pretax Income Growth
| +25.91% | +15.80% | -12.07% | +38.45% | |
Pretax Margin
| +11.30% | +12.04% | +9.47% | +12.29% | |
Income Tax
| 458.22M | 577.32M | 532.19M | 665.86M | |
Income Tax - Current - Domestic
| 444.56M | 589.21M | 603.58M | 707.62M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| 13.66M | (11.89M) | (71.39M) | (41.76M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 1.60B | 1.80B | 1.56B | 2.23B | |
Minority Interest Expense
| - | 13.66M | 28.12M | 41.76M | |
Net Income
| 1.58B | 1.80B | 1.53B | 2.19B | |
Net Income Growth
| +36.54% | +13.85% | -14.99% | +42.89% | |
Net Margin Growth
| +8.71% | +9.12% | +6.94% | +9.29% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 1.58B | 1.80B | 1.53B | 2.19B | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 1.58B | 1.80B | 1.53B | 2.19B | |
EPS (Basic)
| 3.468 | 3.9311 | 3.3344 | 4.8064 | |
EPS (Basic) Growth
| +36.25% | +13.35% | -15.18% | +44.15% | |
Basic Shares Outstanding
| 457.00M | 459.00M | 460.00M | 456.00M | |
EPS (Diluted)
| 3.4604 | 3.9311 | 3.3272 | 4.8064 | |
EPS (Diluted) Growth
| +36.25% | +13.60% | -15.36% | +44.46% | |
Diluted Shares Outstanding
| 458.00M | 459.00M | 461.00M | 456.00M | |
EBITDA
| 3.23B | 3.38B | 3.61B | 4.20B | |
EBITDA Growth
| +6.17% | +4.64% | +6.67% | +16.37% | |
EBITDA Margin
| +17.77% | +17.10% | +16.33% | +17.81% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 95.80 | |
| Number of Ratings | 22 | Current Quarters Estimate | 2.287 | |
| FY Report Date | 12 / 2026 | Current Year's Estimate | 4.479 | |
| Last Quarter’s Earnings | N/A | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 4.11 | Next Fiscal Year Estimate | 4.89 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 1 | 1 | 18 | 19 |
| Mean Estimate | 2.29 | 2.40 | 4.48 | 4.89 |
| High Estimates | 2.29 | 2.40 | 4.54 | 5.05 |
| Low Estimate | 2.29 | 2.40 | 4.29 | 4.67 |
| Coefficient of Variance | N/A | N/A | 1.21 | 1.62 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 10 | 10 | 11 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 7 | 7 | 6 |
| UNDERWEIGHT | 2 | 2 | 2 |
| SELL | 2 | 1 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Coca-cola Europacific Partners Plc - CCEP
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Coca-cola Europacific Partners Plc - CCEP
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Stephen James Lusk | N/A | Open market or private purchase of non-derivative security Non-derivative transaction at $108.31 per share | 0.00 |
| Sep 1, 2026 | Stephen James Lusk | N/A | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Sep 1, 2026 | Stephen James Lusk | N/A | Open market or private purchase of non-derivative security Non-derivative transaction at $108.31 per share | 0.00 |
| Sep 1, 2026 | Svetlana Walker | N/A | Open market or private purchase of non-derivative security Non-derivative transaction at $108.31 per share | 0.00 |
| Sep 1, 2026 | Stephen Moorhouse | N/A | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Sep 1, 2026 | Stephen Moorhouse | N/A | Open market or private purchase of non-derivative security Non-derivative transaction at $108.31 per share | 0.00 |
| Sep 1, 2026 | Svetlana Walker | N/A | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Sep 1, 2026 | Edward Owen Walker | N/A | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Sep 1, 2026 | Svetlana Walker | N/A | Open market or private purchase of non-derivative security Non-derivative transaction at $108.31 per share | 0.00 |
| Sep 1, 2026 | Leendert Den Hallander | N/A | Open market or private purchase of non-derivative security Non-derivative transaction at $108.31 per share | 0.00 |
| Sep 1, 2026 | Leendert Den Hallander | N/A | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Sep 1, 2026 | Edward Owen Walker | N/A | Open market or private purchase of non-derivative security Non-derivative transaction at $108.31 per share | 0.00 |
| Jun 25, 2026 | José Antonio Echeverría | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $97.95 per share | 0.00 |
| Jun 4, 2026 | Damian Paul Gammell | N/A | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 4, 2026 | Stephen James Lusk | N/A | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 17, 2026 | Ana Callol | N/A | Open market or private purchase of non-derivative security Non-derivative transaction at $96.76 per share | 0.00 |
| Apr 17, 2026 | José Antonio Echeverría | N/A | Open market or private purchase of non-derivative security Non-derivative transaction at $96.76 per share | 0.00 |
| Mar 25, 2026 | Mary Elaine Harris | N/A | Open market or private purchase of non-derivative security Non-derivative transaction at $81.6 per share | 0.00 |
| Mar 13, 2026 | Stephen Moorhouse | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $108.55 per share | 0.00 |
| Mar 13, 2026 | Stephen Moorhouse | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $108.59 per share | 0.00 |